Blueberry Anthocyanins and the Brain

Anthocyanins and Brain — scientific infographic poster

Blueberries have been tested for cognitive effects in a series of randomized human trials in older adults and school-age children, with mixed results: a 2025 meta-analysis of nine trials in older adults with mild cognitive impairment or subjective cognitive decline found improved episodic memory but no improvement in processing speed or working memory, and a 2026 meta-analysis of 14 trials in healthy people found no significant effect on executive function. The active molecules are the anthocyanin pigments — particularly cyanidin-3-glucoside, delphinidin-3-glucoside, and malvidin-3-glucoside — that give blueberries their characteristic dark color. These compounds cross the blood-brain barrier at low but measurable nanomolar concentrations, have been found in the cortex, hippocampus, cerebellum and striatum of blueberry-fed rats, and in rat studies upregulate brain-derived neurotrophic factor (BDNF), the master signaling molecule for synaptic plasticity and adult neurogenesis. This deep-dive walks through each mechanism, the pivotal Krikorian and Whyte trials, and the amounts of blueberries used in those trials.


Table of Contents

  1. Why Blueberries Specifically for the Brain
  2. Blood-Brain Barrier Crossing & Brain Distribution
  3. Brain-Derived Neurotrophic Factor Upregulation & Synaptic Plasticity
  4. Cerebral Blood Flow & Neurovascular Coupling
  5. Neuroinflammation & Microglial Quieting
  6. The Krikorian Blueberry and Memory Trials
  7. The Whyte Reading Children's Trials
  8. Alzheimer's Disease & Long-Term Cognitive Decline
  9. Amounts Used in the Trials
  10. Cautions & What the Evidence Does Not Support
  11. Key Research Papers
  12. Connections
  13. Featured Videos

Why Blueberries Specifically for the Brain

Many fruits contain polyphenols. Many polyphenols have antioxidant effects in test tubes. Very few have produced reproducible cognitive effects in randomized human trials. Blueberries have been tested more than most, and the interest traces to three properties of the anthocyanin chemistry not shared by, say, apple quercetin or tea catechins.

First, anthocyanin glycosides are unusually stable at intestinal pH compared to most flavonoids, surviving the stomach's acid environment without immediate degradation. Second, their metabolites (protocatechuic acid, phloroglucinaldehyde, vanillic acid, ferulic acid) produced by colonic microbial action are themselves bioactive and have longer half-lives than the parent compounds; in a human tracer study, metabolites stayed in the circulation for up to 48 hours. Third, and most consequentially, both the parent anthocyanins and the metabolites have measurable transport across the blood-brain barrier — a property quercetin and most flavanols largely lack.

The research line began in animals. In the foundational James Joseph rat studies at the U.S. Department of Agriculture (USDA) Human Nutrition Research Center on Aging at Tufts, aged rats fed blueberry-enriched diets recovered psychomotor function on the rotarod that was lost in their non-supplemented littermates. Subsequent human work has shown analogous effects in older adults — Krikorian's blueberry trials reported improvements in paired associate learning and word-list recall (2010, older adults with early memory changes) and in lexical access and memory interference (2022, middle-aged adults with subjective cognitive decline) after 12 weeks. The effect is not the kind of "feel sharper" subjective improvement that often fails replication; it is measurable on standardized neuropsychological batteries.

For the parallel evidence on insulin sensitivity (which has its own pathway to cognitive protection via blood-sugar stability), see our Insulin Sensitivity page. The two effects compound: metabolic protection plus direct neurotropic action.

Back to Table of Contents

Blood-Brain Barrier Crossing & Brain Distribution

For decades, the rote dismissal of cognitive claims for dietary polyphenols was "they don't cross the blood-brain barrier in physiologically meaningful concentrations." For most polyphenols this remains true. For anthocyanins, the evidence is now solidly to the contrary.

Andres-Lacueva and colleagues fed 19-month-old rats a 2% blueberry diet for 8-10 weeks and, using liquid chromatography-mass spectrometry (LC-MS), found several anthocyanins (cyanidin, malvidin, peonidin and delphinidin glycosides) in the cerebellum, cortex, hippocampus or striatum of the blueberry-fed rats but not the controls. The rats' performance in a water maze, a test of spatial learning and memory, was related to the total number of anthocyanin compounds found in the cortex.

Pig studies show a similar pattern. Kalt and colleagues fed pigs blueberry diets and recovered intact anthocyanins from cortical and cerebellar tissue. In humans, Czank and colleagues gave eight men 500 mg of carbon-13-labeled cyanidin-3-glucoside and traced the label and its metabolites in blood, urine, breath and feces over 48 hours; the metabolites were present in the circulation for up to 48 hours. Brain tissue was not measured in that study.

The transport mechanism is not fully resolved but appears to involve a combination of:

The brain concentrations are low compared to plasma, but the relevant comparison is to the half-maximal inhibitory concentration (IC50) values for the molecular targets (modulation of the brain-derived neurotrophic factor receptor TrkB, or tropomyosin receptor kinase B; suppression of nuclear factor kappa B (NF-kB); activation of nuclear factor erythroid 2-related factor 2 (Nrf2)), which are themselves in the nanomolar range. The doses are sufficient.

Back to Table of Contents

Brain-Derived Neurotrophic Factor Upregulation & Synaptic Plasticity

Brain-derived neurotrophic factor (BDNF) is the most important single molecule for adult brain plasticity. It promotes survival of existing neurons, the growth of new synapses, the strengthening of synaptic connections during long-term potentiation (LTP), and the maturation of newborn neurons in the dentate gyrus of the hippocampus. Brain-derived neurotrophic factor levels decline with age, are reduced in depression, and are profoundly suppressed in Alzheimer's disease.

Anything that raises brain-derived neurotrophic factor is potentially neuroprotective. The most powerful brain-derived neurotrophic factor inducers known are aerobic exercise (which can double serum brain-derived neurotrophic factor acutely) and intermittent fasting / ketosis (which raises brain-derived neurotrophic factor via beta-hydroxybutyrate (BHB) acting on hydroxycarboxylic acid receptor 2 (HCAR2)). Blueberry anthocyanins are a much weaker brain-derived neurotrophic factor inducer but consistently raise hippocampal brain-derived neurotrophic factor mRNA expression by 20-40% in animal studies.

The Williams 2008 trial in aged rats showed that 12 weeks of blueberry supplementation improved spatial working memory on the radial-arm water maze, and the improvement correlated with activation of hippocampal cAMP-response element-binding protein (CREB) and brain-derived neurotrophic factor protein levels. CREB phosphorylation is the downstream signaling event that translates synaptic activity into the gene transcription required for memory consolidation. In that study the CREB and brain-derived neurotrophic factor changes were accompanied by increased phosphorylation of extracellular signal-related kinase (ERK1/2), rather than of calcium calmodulin kinase (CaMKII and CaMKIV) or protein kinase A; the authors link the memory changes to flavonoid effects on the ERK-CREB-BDNF pathway.

The translation to human imaging is less direct (you cannot routinely measure human hippocampal brain-derived neurotrophic factor), but the Krikorian trials showed cognitive improvements in memory-impaired older adults that mechanistically fit the brain-derived neurotrophic factor hypothesis: the most improved scores were on memory tests heavily dependent on hippocampal function (verbal paired-associate learning, list-learning) rather than tests dependent on other brain regions.

Back to Table of Contents

Cerebral Blood Flow & Neurovascular Coupling

A second mechanism, distinct from brain-derived neurotrophic factor, is improved cerebral blood flow. Bowtell and colleagues used arterial spin labeling magnetic resonance imaging (MRI) to measure resting brain blood flow (perfusion) and task-related brain activation in healthy older adults after 12 weeks of daily blueberry concentrate (30 mL providing 387 mg anthocyanidins) or an isoenergetic placebo. Grey-matter perfusion rose in the parietal lobe (5.0% vs -2.9% with placebo) and the occipital lobe (8.0% vs -0.7%), brain activation increased in several areas during a numerical Stroop test, and there was evidence suggesting better working memory on a 2-back test (p = 0.05).

The mechanism is consistent with what is known about anthocyanin effects on the systemic vasculature: anthocyanins increase endothelial nitric oxide synthase (eNOS) expression, improve nitric-oxide bioavailability, and improve flow-mediated dilation of conduit arteries. The cerebral vasculature shares this endothelial biology, and improved cerebral perfusion is itself associated with cognitive performance in aging populations.

A 2026 meta-analysis of 14 randomized trials (632 healthy participants) found that blueberry intake improved flow-mediated dilation, a measure of how well arteries widen, by 1.11%, but found no significant change in systolic or diastolic blood pressure and no significant effect on executive function (standardized mean difference, SMD 0.21) or mood. The authors describe the effect on cognitive performance as inconclusive.

The acute effect is also measurable. In a 2016 trial by Whyte and colleagues, 21 children aged 7-10 drank a placebo or a drink with 15 or 30 g of freeze-dried wild blueberry powder; compared with placebo, the blueberry drinks improved immediate word recall at 1.15 hours, delayed word recognition, and accuracy on the hardest trials of an interference task at 3 hours. The time course matches plasma anthocyanin peak and a transient improvement in cerebral perfusion rather than the slower brain-derived neurotrophic factor / synaptic mechanism.

For more on the cardiovascular side of the same biology, see our Atherosclerosis page — the same endothelial mechanisms underlie the cardiovascular epidemiology in Cassidy's Nurses' Health Study analysis.

Back to Table of Contents

Neuroinflammation & Microglial Quieting

Microglia are the resident immune cells of the brain. Under normal conditions they survey the parenchyma in a ramified, "quiet" state. Under inflammatory provocation (infection, traumatic injury, accumulated amyloid plaque) they shift to an activated, amoeboid phenotype that secretes pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1-beta, interleukin-6) and reactive oxygen species. Sustained microglial activation is now understood as a central driver of age-related cognitive decline and Alzheimer's disease pathology.

Anthocyanins and their metabolites suppress microglial activation through at least three pathways:

  1. NF-kB inhibition — protocatechuic acid (the dominant cyanidin metabolite) directly inhibits I-kappa-B-kinase, blocking nuclear translocation of NF-kB and thus the transcription of pro-inflammatory cytokine genes.
  2. Nrf2 activation — the same metabolite stabilizes Nrf2, the master transcription factor for endogenous antioxidant defense. This upregulates heme oxygenase-1, NAD(P)H quinone dehydrogenase 1 (NQO1), glutathione synthesis enzymes, and other components of the cellular antioxidant machinery.
  3. Direct radical scavenging in the activated microglial microenvironment, reducing the local oxidative damage that perpetuates the inflammatory feedback loop.

In the Goyarzu 2004 study, aged rats fed a 2% blueberry diet for 4 months had significantly lower levels of NF-kB than aged rats on the control diet in four of the five brain regions measured, and performed an object-recognition memory task as well as young rats, while aged rats on the control diet performed no better than chance. This is the cellular-level finding behind the broader "anti-aging brain" framing of blueberries in the popular literature.

Back to Table of Contents

The Krikorian Blueberry and Memory Trials

Robert Krikorian has led a long-running program of human trials on blueberry and cognition. The 2010 pilot trial enrolled 9 older adults with early memory changes. Participants drank a daily wild blueberry juice equivalent to 6-9 mL/kg body weight for 12 weeks.

Results:

The pilot had no placebo group of its own: the authors compared the blueberry group with a demographically matched group who drank a berry placebo beverage in a companion trial of identical design, and observed comparable results for paired associate learning.

A 2022 randomized, double-blind, placebo-controlled trial moved earlier in life. It enrolled overweight, insulin-resistant men and women aged 50 to 65 with subjective cognitive decline, who took a daily blueberry powder (half a cup of whole-fruit equivalent) or a placebo powder for 12 weeks. The blueberry group improved on measures of lexical access (p = 0.003) and memory interference (p = 0.04), reported less memory-encoding difficulty in daily life (p = 0.03), and showed correction of raised fasting insulin (hyperinsulinemia, p = 0.04).

The Krikorian trials are not large by Alzheimer's-drug standards (no n=2,000 multi-site Phase III trial exists for blueberries). A 2025 meta-analysis pooled nine randomized trials (513 older adults with mild cognitive impairment or subjective cognitive decline): blueberry intake improved episodic memory (SMD 0.34) and, in mild cognitive impairment, language memory (SMD 0.30), but showed no improvement in processing speed, recognition memory, visuospatial learning or working memory. The authors call for further multicenter trials to confirm the findings.

For an adjacent line of evidence on the same population (mild cognitive impairment as a transitional state between normal aging and Alzheimer's), see our Alzheimer's Disease page.

Back to Table of Contents

The Whyte Reading Children's Trials

The other major program of human trials on blueberry and cognition is at the University of Reading in the UK, led by Adrian Whyte and Claire Williams. Their innovation was to study acute effects in children — a population in which baseline cognitive performance is high, learning is the daily occupation, and any improvement is immediately educationally meaningful.

The 2015 Whyte and Williams paper in Nutrition enrolled 14 children aged 8-10 in a crossover design and gave them either a flavonoid-rich blueberry drink or a matched vehicle drink. Cognitive testing 2 hours after the drink showed, compared with the vehicle:

The 2016 follow-up (21 children aged 7-10, 15 or 30 g of freeze-dried wild blueberry powder, tests at 1.15, 3 and 6 hours) found better immediate recall, delayed word recognition and accuracy on demanding interference trials, with the best performance after the 30 g dose.

A subsequent trial extended this to a 7-week chronic intervention with daily blueberry intake during a school term. Children in the active group showed improvements in episodic memory and executive function relative to placebo across the term, suggesting both acute and accumulated effects.

The acute effect is mechanistically explained by improved cerebral blood flow and possibly modulation of monoamine neurotransmission (anthocyanins have weak monoamine oxidase B (MAO-B) inhibitor activity, which can transiently elevate dopamine in synaptic clefts). The chronic effect overlaps the brain-derived neurotrophic factor/synaptic mechanism described earlier.

Back to Table of Contents

Alzheimer's Disease & Long-Term Cognitive Decline

Three threads of evidence connect blueberry consumption to Alzheimer's and long-term cognitive decline:

  1. Animal models of Alzheimer's — transgenic mice overexpressing human amyloid precursor protein (the APP/PS1 model; PS1 is presenilin 1) develop amyloid plaques and cognitive deficits at 6-9 months. Blueberry-fed mice show delayed amyloid accumulation, preserved hippocampal-dependent memory, and reduced microglial activation. The mechanism appears to be both direct (anthocyanin-mediated suppression of beta-secretase activity, reducing amyloid generation) and indirect (anti-inflammatory and brain-derived neurotrophic factor-mediated neuroprotection).
  2. The MIND diet — the Mediterranean-DASH Intervention for Neurodegenerative Delay developed by Morris and colleagues at Rush University identified ten specific food groups associated with reduced Alzheimer's risk in the Rush Memory and Aging Project cohort. Berries are one of the ten; the recommendation is two or more servings per week. Adherence to the MIND diet was associated with a 53% reduction in Alzheimer's incidence over follow-up. A 3-year randomized trial of the MIND diet (604 older adults without cognitive impairment but with a family history of dementia and a body-mass index above 25; New England Journal of Medicine 2023) then compared it with a control diet, both with mild caloric restriction: global cognition scores rose by 0.205 standardized units on the MIND diet and 0.170 on the control diet, a difference that was not significant (P = 0.23), and brain MRI changes were similar in the two groups.
  3. The Devore Annals of Neurology 2012 paper — analyzed 16,010 women aged 70 or older from the Nurses' Health Study, whose cognitive testing began in 1995-2001 with two follow-up assessments at 2-year intervals. Greater intakes of blueberries and of strawberries were each associated with slower rates of cognitive decline; the authors estimate that berry intake appears to delay cognitive aging by up to 2.5 years.

The translation to a definitive randomized trial in older adults with cognitive decline has not yet been done at the scale that would warrant a pharmaceutical-level claim. The available evidence is biologically plausible but the trial sizes are too small to detect or rule out disease-modifying effects on Alzheimer's as such. Taken together, the evidence describes blueberries (and berries more broadly) within a Mediterranean-pattern diet as low-risk, with a possible benefit for cognitive aging that larger trials have yet to confirm.

Back to Table of Contents

Amounts Used in the Trials

The amounts used in the published trials cluster in a narrow range:

For scale, everyday servings of blueberries look like this:

For individuals who cannot tolerate the volume of fruit (or its sugar load), freeze-dried blueberry powder is an alternative, typically dosed at 20-25 g/day (about 2 tablespoons) mixed into water, kefir, or a smoothie. This delivers approximately the same anthocyanin content as 1 cup of fresh berries at a similar or lower cost-per-anthocyanin.

Anthocyanin-only extract capsules (cyanidin-3-glucoside isolates, bilberry extracts standardized to 25% anthocyanins) are also available but lose the dietary fiber, vitamin C, and broader polyphenol matrix of whole fruit. The available human-trial evidence is on the whole fruit and not the isolated extracts.

Back to Table of Contents

Cautions & What the Evidence Does Not Support

Back to Table of Contents

Key Research Papers

  1. Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA (2010). Blueberry supplementation improves memory in older adults. Journal of Agricultural and Food Chemistry 58(7):3996-4000 — PubMed PMID: 20047325
  2. Whyte AR, Williams CM (2015). Effects of a single dose of a flavonoid-rich blueberry drink on memory in 8 to 10 year old children. Nutrition 31(3):531-534 — PubMed PMID: 25701345
  3. Whyte AR, Schafer G, Williams CM (2016). Cognitive effects following acute wild blueberry supplementation in 7- to 10-year-old children. European Journal of Nutrition 55(6):2151-2162 — PubMed PMID: 26437830
  4. Bowtell JL, Aboo-Bakkar Z, Conway ME, Adlam AR, Fulford J (2017). Enhanced task-related brain activation and resting perfusion in healthy older adults after chronic blueberry supplementation. Applied Physiology, Nutrition, and Metabolism 42(7):773-779 — PubMed PMID: 28249119
  5. Williams CM et al. (2008). Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and BDNF levels. Free Radical Biology and Medicine 45(3):295-305 — PubMed PMID: 18457678
  6. Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA (2005). Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutritional Neuroscience 8(2):111-120 — PubMed PMID: 16053243
  7. Joseph JA et al. (1999). Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. Journal of Neuroscience 19(18):8114-8121 — PubMed PMID: 10479711
  8. Devore EE, Kang JH, Breteler MM, Grodstein F (2012). Dietary intakes of berries and flavonoids in relation to cognitive decline. Annals of Neurology 72(1):135-143 — PubMed PMID: 22535616
  9. Galli RL, Bielinski DF, Szprengiel A, Shukitt-Hale B, Joseph JA (2006). Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiology of Aging 27(2):344-350 — PubMed PMID: 15869824
  10. Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT (2015). MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia 11(9):1007-1014 — PubMed PMID: 25681666
  11. Krikorian R, Skelton MR, Summer SS, Shidler MD, Sullivan PG (2022). Blueberry supplementation in midlife for dementia risk reduction. Nutrients 14(8):1619 — PubMed PMID: 35458181
  12. Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD (2013). Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. American Journal of Clinical Nutrition 97(5):995-1003 — PubMed PMID: 23604435
  13. Goyarzu P, Malin DH, Lau FC, Taglialatela G, Moon WD, Jennings R, Moy E, Moy D, Lippold S, Shukitt-Hale B, Joseph JA (2004). Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutritional Neuroscience 7(2):75-83 — PubMed PMID: 15279493
  14. da Silva ABN, de Oliveira GM, Gallo Ruelas M, Gadelha MSM, de Farias Santos ACF, Zamora FV (2025). Blueberries for brainpower: A systematic review and meta-analysis with Bayesian post hoc analysis of RCTS exploring cognitive function in the elderly with prior cognitive decline. Biogerontology 26(5):171 — PubMed PMID: 40856863
  15. He Y, Yang J, Zhang S, Mai J, Li M (2026). Blueberry consumption enhances vascular function but not cognitive abilities in healthy individuals: a systematic review and meta-analysis. Nutrition Research 149:162-177 — PubMed PMID: 41974068
  16. Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, Hollings CS, Bishop L, Laranjo N, Stubbs BJ, Reilly X, Agarwal P, Zhang S, Grodstein F, Tangney CC, Holland TM, Aggarwal NT, Arfanakis K, Morris MC, Sacks FM (2023). Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine 389(7):602-611 — PubMed PMID: 37466280
  17. Guardino ET, Gabriel O, Mukamal KJ, Djousse L (2026). Effects of a 24-week intervention with freeze-dried blueberries on brain health in older adults: A randomized double-blind, placebo-controlled trial. Clinical Nutrition ESPEN 74:103377 — PubMed PMID: 42251891

PubMed Topic Searches

  1. PubMed: Blueberry cognition human trials
  2. PubMed: Anthocyanin BDNF hippocampus
  3. PubMed: Blueberry and MCI
  4. PubMed: Anthocyanin blood-brain barrier
  5. PubMed: MIND diet, Alzheimer's, berries

Back to Table of Contents

Connections

Back to Table of Contents